| |
 |
|
Class Information
Number: 546/153
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) or nitrogen as the only ring hetero atoms (class 540, subclass 1) > Hetero ring is six-membered consisting of one nitrogen and five carbons > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Bicyclo ring system having the six-membered hetero ring as one of the cyclos > Quinolines (including hydrogenated) > Chalcogen attached directly to the six-membered hetero ring by nonionic bonding
Description: Compounds in which chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) is attached directly to the six-membered hetero ring of the quinoline ring system by nonionic bonding.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7825115 |
Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
Nov. 2, 2010 |
| 7820824 |
Modified carbocyanine dyes and their conjugates |
Oct. 26, 2010 |
| 7820823 |
Dual action antibiotics |
Oct. 26, 2010 |
| 7812168 |
Purification of montelukast |
Oct. 12, 2010 |
| 7799774 |
Quinoline derivatives and their use as 5-HT.sub.6 ligands |
Sep. 21, 2010 |
| 7790893 |
Modified carbocyanine dyes and their conjugates |
Sep. 7, 2010 |
| 7790726 |
Monocyclic and bicyclic compounds and methods of use |
Sep. 7, 2010 |
| 7781589 |
Quantitative method of determining beryllium or a compound thereof in a sample |
Aug. 24, 2010 |
| 7772250 |
Compounds |
Aug. 10, 2010 |
| 7732613 |
Met kinase inhibitors |
Jun. 8, 2010 |
| 7728142 |
3-methanesulfonylquinolines as GABA.sub.B enhancers |
Jun. 1, 2010 |
| 7728007 |
Therapeutic amides |
Jun. 1, 2010 |
| 7718806 |
Process for production of carbostyril compound |
May. 18, 2010 |
| 7683172 |
Urea derivative and process for preparing the same |
Mar. 23, 2010 |
| 7652141 |
Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
Jan. 26, 2010 |
| 7638533 |
Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
Dec. 29, 2009 |
| 7632783 |
3-(dihydro(tetrahydro)isoquinolin-1-yl)quinoline compound |
Dec. 15, 2009 |
| 7626030 |
Compounds and methods of use |
Dec. 1, 2009 |
| 7619090 |
Monocyclopentadienyl complexes comprising a condensed heterocycle |
Nov. 17, 2009 |
| 7612208 |
Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinoli- necarboxamide or the solvate of the salt and a process for preparing the same |
Nov. 3, 2009 |
| 7612092 |
Nitrogen-containing aromatic derivatives |
Nov. 3, 2009 |
| 7601841 |
Quinolinyl and benzothiazolyl modulators |
Oct. 13, 2009 |
| 7598390 |
Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
Oct. 6, 2009 |
| 7598384 |
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
Oct. 6, 2009 |
| 7595402 |
Prodrugs of selective androgen receptor modulators and methods of use thereof |
Sep. 29, 2009 |
| 7592456 |
Arylsulfonylnaphthalene derivatives as 5HT.sub.2A antagonists |
Sep. 22, 2009 |
| 7589209 |
8-hydroxyquinoline tripodal metal ion probes |
Sep. 15, 2009 |
| 7589208 |
Compositions containing quinoline compounds |
Sep. 15, 2009 |
| 7585845 |
Hepatitis C inhibitor compounds |
Sep. 8, 2009 |
| 7579473 |
c-Met modulators and methods of use |
Aug. 25, 2009 |
| 7576215 |
Quinolines and pharmaceutical compositions thereof |
Aug. 18, 2009 |
| 7563805 |
Tri-, tetra-substituted-3-aminopyrrolidine derivative |
Jul. 21, 2009 |
| 7553967 |
1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections |
Jun. 30, 2009 |
| 7553854 |
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
Jun. 30, 2009 |
| 7550598 |
Kinase inhibitors |
Jun. 23, 2009 |
| 7550597 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
Jun. 23, 2009 |
| 7550483 |
Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinoli- necarboxamide and process for preparing the same |
Jun. 23, 2009 |
| 7547787 |
Processes for preparing montelukast sodium |
Jun. 16, 2009 |
| 7544803 |
Vanilloid receptor ligands and their use in treatments |
Jun. 9, 2009 |
| 7544798 |
Process for preparing macrocyclic compounds |
Jun. 9, 2009 |
| 7541466 |
Tetrahydroisoquinoline derivatives for treating protein trafficking diseases |
Jun. 2, 2009 |
| 7541465 |
Substituted 2-aminoacetamides and the use thereof |
Jun. 2, 2009 |
| 7534890 |
Process for preparing 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1H)-qu- inolin-2-one salt, useful as an andrenoceptor agonist |
May. 19, 2009 |
| 7534802 |
Compounds having 4-pyridylalkylthio group as substituent |
May. 19, 2009 |
| 7534793 |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
May. 19, 2009 |
| 7531577 |
Arylsulfonamidyl tetralin derivatives and uses thereof |
May. 12, 2009 |
| 7531554 |
4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
May. 12, 2009 |
| 7531553 |
Heterocyclic compounds and methods of use |
May. 12, 2009 |
| 7521560 |
2-substituted quinoline compounds and their uses |
Apr. 21, 2009 |
| 7517987 |
Caspase inhibitors and uses thereof |
Apr. 14, 2009 |
|
|
|
